Eisai Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Total-Revenue" stands at 804.39 Billion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025, the highest value at least since 03/31/2012, the period currently displayed.
Eisai Co. Ltd.'s second quarter result of 197.36 Billion JPY for the item "Total Revenue" represents a decrease of -2.61 percent compared to it's first quarter result.
Also, Eisai Co. Ltd.'s second quarter result of 197.36 Billion JPY for the item "Total Revenue" represents an increase of 0.7 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Eisai Co. Ltd.'s second quarter result of 804.39 Billion JPY for the item "Total Revenue" represents an increase of 0.17 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 6.79 percent compared to the value the year prior.
The 1 year change in percent is 6.79.
The 3 year change in percent is 6.90.
The 5 year change in percent is 12.75.
The 10 year change in percent is 44.96.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Total Revenue | 905,699,262,464.00 |
![]() | Johnson & Johnson - Total Revenue | 486,508,953,600.00 |
![]() | AbbVie Inc - Total Revenue | 399,570,305,024.00 |
![]() | Roche Holding AG - Total Revenue | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Total Revenue | 280,205,508,085.11 |